Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 3/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | CD40 | P25942 | 2/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | GHSR | Q92847 | 1/20 | 0.34 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.33 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.33 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.33 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.33 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7160634 | 1.00 | MMP2 (0.37) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL10525648 | 0.97 | CD40 (0.33) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL9616877 | 0.92 | MMP2 (0.39) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL9200315 | 0.92 | MMP2 (0.39) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL8427968 | 0.92 | MMP2 (0.39) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL9183876 | 0.90 | MMP2 (0.36) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL18568245 | 0.89 | MMP2 (0.35) | MMP2TERTSLC15A2CD40DPP8 | |
| SCHEMBL29484171 | 0.89 | SLC15A2 (0.41) | MMP2TERTSLC15A2CD40GHSR | |
| SCHEMBL10524626 | 0.87 | SIRT6 (0.43) | SLC15A2 | |
| SCHEMBL10524634 | 0.87 | SIRT6 (0.43) | SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | claimed |
| CN-119708124-A | Liquid phase synthesis method of bursin tripeptide | 厦门胜泽泰医药科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119462827-A | Semi-continuous liquid phase synthesis method of bursin tripeptide | 漳州胜泽泰医药科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119015217-A | Wound care ointment and preparation method thereof | 广州万力医疗科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118909036-A | Hyaluronic acid graft bursin tripeptide polymer and preparation method and application thereof | 江苏省农业科学院 | 2024-11-08 | — | — | CN | claimed |
| CN-118662624-A | Vaccine formula for preventing avian influenza | 商丘美兰生物工程有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024079738-A1 | ORAL POLYPEPTIDE FORMULATIONS | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | WO | claimed |
| WO-2024079739-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | WO | claimed |
| US-20240122847-A1 | ORAL POLYPEPTIDE FORMULATIONS | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | US | claimed |
| US-20240122860-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | US | claimed |
| CN-109966484-B | Immunopotentiator, preparation method, avian influenza vaccine and application | 肇庆大华农生物药品有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-110591852-B | Application and method of eurotium scherzeri in microbial rejuvenation of pit mud of white spirit cellar | 山东扳倒井股份有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-114805472-A | Preparation method of chicken bursa of Fabricius bursin | 福建农业职业技术学院 | 2022-07-29 | — | — | CN | claimed |
| CN-114552122-A | Diaphragm, preparation method thereof and secondary battery | 惠州锂威电子科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| EP-0506628-B1 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | SIGMA TAU IND FARMACEUTI (IT) | 1996-09-18 | — | — | EP | claimed |
| EP-0506628-A2 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-09-30 | — | — | EP | claimed |
| EP-0464009-A2 | Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-01-02 | — | — | EP | claimed |
| US-12622922-B2 | Compositions and methods for metal containing formulations capable of modulating immune response | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | disclosed |
| CN-121574195-A | Hexapeptide isolated from bursa of Fabricius and its use in immunomodulation | 青岛农业大学 | 2026-02-27 | — | — | CN | disclosed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | disclosed |
| US-20250375388-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | UNIV MICHIGAN REGENTS (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | disclosed |
| US-20250213474-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-07-03 | — | — | US | disclosed |
| CN-119925199-A | Papain composition and preparation method and application thereof | 广州柏为科技有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-117442542-B | Skin soothing composition and skin care product | 广州天然国度生物科技有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119744164-A | Odor and colorant stable compositions | 西姆莱斯股份公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119708124-A | Liquid phase synthesis method of bursin tripeptide | 厦门胜泽泰医药科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119708124-A | Liquid phase synthesis method of bursin tripeptide | 厦门胜泽泰医药科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119708124-A | Liquid phase synthesis method of bursin tripeptide | 厦门胜泽泰医药科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-12257352-B2 | Compositions and methods for delivery of biomacromolecule agents | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-03-25 | — | — | US | disclosed |
| CN-112672763-B | Compositions and methods for metal-containing formulations capable of modulating immune responses | 密执安大学评议会 | 2025-03-25 | — | — | CN | disclosed |
| CN-119529022-A | Tetrapeptides isolated from bursa of Fabricius and their use in immunomodulation | 青岛农业大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119462827-A | Semi-continuous liquid phase synthesis method of bursin tripeptide | 漳州胜泽泰医药科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462827-A | Semi-continuous liquid phase synthesis method of bursin tripeptide | 漳州胜泽泰医药科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462827-A | Semi-continuous liquid phase synthesis method of bursin tripeptide | 漳州胜泽泰医药科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119015217-A | Wound care ointment and preparation method thereof | 广州万力医疗科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118949023-A | Low-temperature emulsified water-in-oil-in-water adjuvant, and use method and application thereof | 天津万牧生生物工程有限责任公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| CN-118909036-A | Hyaluronic acid graft bursin tripeptide polymer and preparation method and application thereof | 江苏省农业科学院 | 2024-11-08 | — | — | CN | disclosed |
| CN-118909036-A | Hyaluronic acid graft bursin tripeptide polymer and preparation method and application thereof | 江苏省农业科学院 | 2024-11-08 | — | — | CN | disclosed |
| CN-118909036-A | Hyaluronic acid graft bursin tripeptide polymer and preparation method and application thereof | 江苏省农业科学院 | 2024-11-08 | — | — | CN | disclosed |
| CN-221938537-U | Quick liquid separating device for chicken bursa of Fabricius extract injection | 陈钧妍 | 2024-11-01 | — | — | CN | disclosed |
| CN-118662624-A | Vaccine formula for preventing avian influenza | 商丘美兰生物工程有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118662624-A | Vaccine formula for preventing avian influenza | 商丘美兰生物工程有限公司 | 2024-09-20 | — | — | CN | disclosed |
| US-20240277751-A1 | CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-08-22 | — | — | US | disclosed |
| CN-118488961-A | HERV-K antibodies, cells, vaccines and pharmaceutical therapeutics | 阳光海岸生物技术股份有限公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-4408480-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | The Regents Of The University Of Michigan (US) | 2024-08-07 | — | — | EP | disclosed |
| CN-118303625-A | Nerve-soothing and sleep-aiding composition, and preparation method, application and product thereof | 北京泰开尔营养科技发展有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118043084-A | Compositions and methods for metal-containing formulations capable of modulating immune responses | 密执安大学评议会 | 2024-05-14 | — | — | CN | disclosed |
| WO-2024079738-A1 | ORAL POLYPEPTIDE FORMULATIONS | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024079739-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | WO | disclosed |
| US-20240122847-A1 | ORAL POLYPEPTIDE FORMULATIONS | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | US | disclosed |
| US-20240122860-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2024-04-18 | — | — | US | disclosed |
| CN-116724888-B | Method for rapidly inducing Alsophila spinulosa cluster buds | 贵州师范大学 | 2024-04-16 | — | — | CN | disclosed |
| CN-114164239-B | Method for preparing ascomycin by efficient fermentation | 福建省微生物研究所 | 2024-03-29 | — | — | CN | disclosed |
| CN-116813795-B | Recombinant AaLS-BSP fusion peptide, preparation method and application | 华中农业大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-116769053-B | Recombinant AaLS-BPP fusion peptide, preparation method and application | 华中农业大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-116813795-A | Recombinant AaLS-BSP fusion peptide, preparation method and application | 华中农业大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116769053-A | Recombinant AaLS-BPP fusion peptide, preparation method and application | 华中农业大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-116724888-A | Method for rapidly inducing Alsophila spinulosa cluster buds | 贵州师范大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-109966484-B | Immunopotentiator, preparation method, avian influenza vaccine and application | 肇庆大华农生物药品有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116390764-A | Crystalline polymorphic forms of STING agonist bound to metal ions capable of modulating immune responses | 密歇根大学董事会 | 2023-07-04 | — | — | CN | disclosed |
| CN-111172049-B | Strain Huang Sugao producing strain and application thereof | 江苏省中国科学院植物研究所 | 2023-05-26 | — | — | CN | disclosed |
| CN-115960185-A | C-type chicken infectious rhinitis subunit vaccine and preparation method and application thereof | 乾元浩生物股份有限公司 | 2023-04-14 | — | — | CN | disclosed |
| WO-2023056427-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-04-06 | — | — | WO | disclosed |
| CN-115819514-A | Application of polypeptide in preparation of newcastle disease vaccine adjuvant or immune synergistic product | 山东省健牧生物药业有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-113694066-B | Application of scirpusin C in preparation of medicine for treating cerebral ischemic stroke | 广东药科大学 | 2023-02-17 | — | — | CN | disclosed |
| US-20230025865-A1 | COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF Bcl-2 AND Bcl-xL ANTAGONISTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-01-26 | — | — | US | disclosed |
| CN-113713779-B | Preparation method of Halocynthia Roretzi nano cellulose based heavy metal adsorbent | 山东大学 | 2023-01-17 | — | — | CN | disclosed |
| CN-115151632-A | Paenibacillus isolate and use thereof | 诺维信生物农业公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-110591852-B | Application and method of eurotium scherzeri in microbial rejuvenation of pit mud of white spirit cellar | 山东扳倒井股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-115068519-A | Application of glossy privet fruit flavone extract in preparing medicine for treating oligospermia | 吉林医药学院 | 2022-09-20 | — | — | CN | disclosed |
| CN-111228133-B | Hair loss prevention and hair growth composition and preparation method thereof | 北京章光101科技股份有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-114805472-A | Preparation method of chicken bursa of Fabricius bursin | 福建农业职业技术学院 | 2022-07-29 | — | — | CN | disclosed |
| CN-114805472-A | Preparation method of chicken bursa of Fabricius bursin | 福建农业职业技术学院 | 2022-07-29 | — | — | CN | disclosed |
| CN-114786654-A | Compositions and methods for systemic delivery of Bcl-2 and Bcl-xL antagonists | 密执安大学评议会 | 2022-07-22 | — | — | CN | disclosed |
| CN-112409454-B | Bursal heptapeptide and preparation method and application thereof | 青岛农业大学 | 2022-07-05 | — | — | CN | disclosed |
| US-20220175872-A1 | THERMOGENIC COMPOSITIONS AND METHODS | OHIO STATE INNOVATION FOUNDATION | 2022-06-09 | — | — | US | disclosed |
| CN-114555030-A | Vaccine product | 扬森疫苗与预防公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-109463744-B | Method for performing solid state fermentation on leucocarp powder by eurotium cristatum, product prepared by method and application of product | 南京林业大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-114469793-A | Biological plant high-foaming washing and protecting liquid for infants | 李昊霖 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022081993-A1 | CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-04-21 | — | — | WO | disclosed |
| CN-112159479-B | Mycoplasma gallisepticum multi-antigen epitope fusion protein pMG-mEA and application thereof | 福建农林大学 | 2022-03-22 | — | — | CN | disclosed |
| US-20220072023-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-03-10 | — | — | US | disclosed |
| US-20030186998-A1 | Methods for treatment of disorders of cardiac contractility | JOHN HOPKINS UNIVERSITY | 2003-10-02 | — | — | US | disclosed |
| US-6569862-B1 | Adminstering xanthine oxidase inhibitor such as allopurinol | JOHNS HOPKINS UNIVERSITY | 2003-05-27 | — | — | US | disclosed |
| EP-1044002-A4 | METHODS FOR TREATMENT OF DISORDERS OF CARDIAC CONTRACTILITY | UNIV JOHNS HOPKINS (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6191136-B1 | ADMINISTERING XANTHINE OXIDASE INHIBITOR | JOHNS HOPKINS UNIVERSITY | 2001-02-20 | — | — | US | disclosed |
| EP-1044002-A1 | METHODS FOR TREATMENT OF DISORDERS OF CARDIAC CONTRACTILITY | JOHNS HOPKINS UNIVERSITY (US) | 2000-10-18 | — | — | EP | disclosed |
| WO-1999024038-A1 | METHODS FOR TREATMENT OF DISORDERS OF CARDIAC CONTRACTILITY | JOHNS HOPKINS UNIVERSITY (US) | 1999-05-20 | — | — | WO | disclosed |
| EP-0506628-B1 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | SIGMA TAU IND FARMACEUTI (IT) | 1996-09-18 | — | — | EP | disclosed |
| US-5550183-A | Metal-peptide compositions and methods for stimulating hair growth | PROCYTE CORPORATION (US) | 1996-08-27 | — | — | US | disclosed |
| WO-1995005195-A1 | PHARMACEUTICAL IMMUNOADJUVANT OR IMMUNOSTIMULATING COMPOSITIONS | LABORATOIRES DOLISOS (FR) | 1995-02-23 | — | — | WO | disclosed |
| US-5298621-A | Peptides endcapped with purine derivative | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1994-03-29 | — | — | US | disclosed |
| US-5298621-A | Peptides endcapped with purine derivative | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1994-03-29 | — | — | US | disclosed |
| US-5272151-A | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1993-12-21 | — | — | US | disclosed |
| US-5272151-A | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1993-12-21 | — | — | US | disclosed |
| EP-0514460-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1992-11-25 | — | — | EP | disclosed |
| EP-0506628-A3 | AMINOACYL AND OLIGOPEPTIDYL DERIVATIVES OF ALLOPURINOL EXHIBITING IMMUNOSTIMULATORY ACTIVITY, AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE SUBSTANCES | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-10-21 | — | — | EP | disclosed |
| EP-0506628-A2 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-09-30 | — | — | EP | disclosed |
| EP-0500745-A1 | METAL-PEPTIDE COMPOSITIONS AND COSMETIC METHODS FOR STIMULATING HAIR GROWTH | PROCYTE CORPORATION (US) | 1992-09-02 | — | — | EP | disclosed |
| US-5120831-A | Hair growth stimulants | PROCYTE CORPORATION (US) | 1992-06-09 | — | — | US | disclosed |
| US-5118665-A | Enhance or restore resistance of mammals to damage caused by release of reactive oxygen species | PROCYTE CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| EP-0190048-B1 | BURSOPOIETIN | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-01-22 | — | — | EP | disclosed |
| EP-0464009-A2 | Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-01-02 | — | — | EP | disclosed |
| EP-0464009-A2 | Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-01-02 | — | — | EP | disclosed |
| WO-1991012267-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1991-08-22 | — | — | WO | disclosed |
| WO-1991007431-A1 | METAL-PEPTIDE COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | PROCYTE CORPORATION (US) | 1991-05-30 | — | — | WO | disclosed |
| US-4866121-A | B cell differentiating peptides and conjugates thereof | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-09-12 | — | — | US | disclosed |
| US-4783442-A | B-cell differentiating peptides | ORTHO PHARMACEUTICAL CORPORATION (US) | 1988-11-08 | — | — | US | disclosed |
| EP-0190048-A2 | Bursopoietin | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-08-06 | — | — | EP | disclosed |
| US-4584284-A | OLIGOPEPTIDE OF LYSINE, HISTIDINE AND GLYCINE-PRODUCING ANTIBODIES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-04-22 | — | — | US | disclosed |
| US-4584284-A | OLIGOPEPTIDE OF LYSINE, HISTIDINE AND GLYCINE-PRODUCING ANTIBODIES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220072023-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | MYD88, STING1, TLR3 | MMP2 3686/4885TERT 3777/4885SLC15A2 3048/4885 |
| US-20250213474-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | MYD88, STING1, TLR3 | MMP2 3686/4885TERT 3777/4885SLC15A2 3048/4885 |
| US-20030186998-A1 | Methods for treatment of disorders of cardiac contractility | TNNI3, TNNT2, RYR2 | MMP2 1203/4885TERT 4361/4885SLC15A2 1903/4885 |
| US-12533321-B2 | Polypeptide formulations for oral delivery | PTMS, IAPP, IGF1R | MMP2 2558/4885TERT 1213/4885SLC15A2 1442/4885 |
| US-20220175872-A1 | THERMOGENIC COMPOSITIONS AND METHODS | LRBA, IAPP, FABP4 | MMP2 370/4885TERT 861/4885SLC15A2 3906/4885 |
| US-20240277751-A1 | CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE | STING1, CGAS, IRF3 | MMP2 4614/4885TERT 4325/4885SLC15A2 1982/4885 |
| US-12622922-B2 | Compositions and methods for metal containing formulations capable of modulating immune response | STING1, CGAS, TLR3 | MMP2 4641/4885TERT 3957/4885SLC15A2 2496/4885 |
| US-20230025865-A1 | COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF Bcl-2 AND Bcl-xL ANTAGONISTS | BCL2, BCL2L2, BCL2L1 | MMP2 588/4885TERT 3207/4885SLC15A2 1253/4885 |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | GLP1R, TTR, IAPP | MMP2 937/4885TERT 1412/4885SLC15A2 361/4885 |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | MMP2 2182/4885TERT 2527/4885SLC15A2 2975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.